Precision BioSciences to Participate in Upcoming Jefferies Cell & Genetic Medicine Summit

Rhea-AI Summary

Precision BioSciences, Inc. (NASDAQ: DTIL) announced its participation in the Jefferies Cell & Genetic Medicine Summit on September 30, 2022, at 2:00 PM ET, located at the Lotte New York Palace Hotel. A recorded webcast will be available on the company’s website shortly after the presentation, with an archived replay accessible for 30 days. The company focuses on developing innovative gene editing therapies using its proprietary ARCUS® platform, targeting genetic and infectious diseases lacking effective treatments. For further details, visit www.precisionbiosciences.com.

DURHAM, N.C.--(BUSINESS WIRE)-- Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that the Company will participate in the Jefferies Cell & Genetic Medicine Summit taking place September 29-30, 2022.

Details for the company presentation are as follows:
Date: Friday, September 30, 2022
Time: 2:00 PM ET
Location: Lotte New York Palace Hotel

The presentation will be available via a recorded webcast accessible on Precision’s website in the Investors section under Events & Presentations: https://investor.precisionbiosciences.com/events-and-presentations. An archived replay will be available for approximately 30 days following the event.

About Precision BioSciences, Inc.

Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly precise and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple ex vivo “off-the-shelf” CAR T immunotherapy clinical candidates and several in vivo gene editing candidates designed to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220922005120/en/

Investor Contact:

Mei Burris

Director, Investor Relations & Finance

Mei.burris@precisionbiosciences.com

Media Contact:

Maurissa Messier

Senior Director, Corporate Communications

Maurissa.Messier@precisionbiosciences.com

Source: Precision BioSciences, Inc.

FAQ

What time is Precision BioSciences presenting at the Jefferies Summit on September 30, 2022?

Precision BioSciences will present at the Jefferies Summit on September 30, 2022, at 2:00 PM ET.

Where will the Jefferies Cell & Genetic Medicine Summit take place?

The Jefferies Summit will be held at the Lotte New York Palace Hotel.

How can I access the webcast of the Precision BioSciences presentation?

The webcast of Precision BioSciences' presentation will be available on their website in the Investors section after the event.

What is the focus of Precision BioSciences?

Precision BioSciences focuses on developing gene editing therapies using its ARCUS® platform to treat genetic and infectious diseases.

How long will the recorded presentation from Precision BioSciences be available?

The archived replay of the presentation will be available for approximately 30 days following the event.